STRONG-DM Study: Heart Failure Prevention in Type 2 Diabetes
This study, called STRONG-DM, is looking at a new way to prevent heart failure in people with type 2 diabetes. It's testing an "Intensive Prevention Strategy" where your primary care doctor would get alerts if you have a high risk of heart failure. These alerts would recommend specific treatments like SGLT2 inhibitors, GLP1 agonists, or non-steroidal MRAs, or suggest a referral to a heart health program. The study wants to see if this strategy can reduce new cases of heart failure or death from any cause over two years. This study is for primary care providers who see patients with diabetes.
- Study design
- This is a pragmatic, randomized clinical trial with a planned enrollment of 300 participants. Primary care providers will be randomly assigned to receive notifications about high-risk patients.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for two years to track incident heart failure or all-cause death.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Incident Heart Failure or All-cause death2-year follow-up
Incident Heart Failure (based on electronic health record International Classification of Diseases codes) or all-cause death. This will be assessed via retrospective chart review.